Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
Rm5hJknm4hyq6WX1
Listen
